256 related articles for article (PubMed ID: 27717335)
1. With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.
Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Chen MY; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
BMC Cancer; 2016 Oct; 16(1):774. PubMed ID: 27717335
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
[TBL] [Abstract][Full Text] [Related]
8. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
Rusthoven CG; Lanning RM; Jones BL; Amini A; Koshy M; Sher DJ; Bowles DW; McDermott JD; Jimeno A; Karam SD
Radiother Oncol; 2017 Jul; 124(1):139-146. PubMed ID: 28433411
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
[No Abstract] [Full Text] [Related]
10. Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer.
Verma V; Allen PK; Simone CB; Gay HA; Lin SH
J Natl Compr Canc Netw; 2017 Nov; 15(11):1383-1391. PubMed ID: 29118230
[No Abstract] [Full Text] [Related]
11. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME
Head Neck; 2016 Apr; 38 Suppl 1():E1102-9. PubMed ID: 26451876
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and outcome for nasopharyngeal carcinoma.
Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004-2008.
Chee Ee Phua V; Loo WH; Yusof MM; Wan Ishak WZ; Tho LM; Ung NM
Asian Pac J Cancer Prev; 2013; 14(8):4567-70. PubMed ID: 24083703
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
17. A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery.
Wang Y; Wang ZQ; Jiang YX; Wang FH; Luo HY; Liang Y; Wang DS; Li YH
Expert Opin Pharmacother; 2016 Aug; 17(12):1585-90. PubMed ID: 27328125
[TBL] [Abstract][Full Text] [Related]
18. Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients.
Sun JD; Chen CZ; Chen JZ; Li DS; Chen ZJ; Zhou MZ; Li DR
Asian Pac J Cancer Prev; 2012; 13(5):2101-7. PubMed ID: 22901177
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
Leong YH; Soon YY; Lee KM; Wong LC; Tham IWK; Ho FCH
Head Neck; 2018 Mar; 40(3):622-631. PubMed ID: 29130584
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
